Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 19 of 19 results found.
Company | Activity | Company Description | Location | |
---|---|---|---|---|
Company Almac Diagnostics LLC | Activity: Contract Research and Testing | Company Description Almac offers services for biomarker discovery, assay development/validation/testing and companion diagnostic co-development. Testing platforms include NGS, Microarray, qPCR and IHC. Regulatory and bioinformatics services are also available. | Location Durham | |
Company BioCytics Inc. | Activity: Research and Development | Company Description BioCytics researches and develops personalized cellular immunotherapy cancer therapies with the latest technology and equipment. BioCytics also offers contract R&D and is co-located with its sister company, the Carolina BioOncology Institute. | Location Huntersville | |
Company BridgeBio Gene Therapy | Activity: Research and Development | Company Description BridgeBio Gene Therapy is developing a gene therapy for the treatment of a monogenic disease that presents in childhood. | Location Raleigh | |
Company Cellectis | Activity: Production and Manufacturing | Company Description Cellectis develops gene-editing technologies and cell therapies to treat cancers of the blood, myeloid, and lymphatic systems. The Raleigh location is the company's GMP manufacturing plant for Cellectis' portfolio of UCART drug products. | Location Raleigh | |
Company Charles River Laboratories (Durham) | Activity: Contract Research and Testing | Company Description Charles River Laboratories' Oncology Center of Excellence provides in vivo and in vitro oncology and immuno-oncology research services. | Location Durham | |
Company Encoded Therapeutics Inc. | Activity: Production and Manufacturing | Company Description Encoded is developing and commercializing gene therapies for pediatric central nervous system (CNS) disorders with its cell-selective targeting and regulation platform. | Location Morrisville | |
Company EpiCypher Inc. | Activity: Research and Development | Company Description EpiCypher develops and manufactures novel products and services for epigenetics and chromatin biology, focused on enabling drug discovery research and development. | Location Durham | |
Company Flagship Biosciences Inc. | Activity: Contract Research and Testing | Company Description Flagship Biosciences provides molecular analysis services for the early diagnosis and treatment of cancer and supporting the development of targeted therapeutics. | Location Morrisville | |
Company Genova Diagnostics Inc. | Activity: Contract Research and Testing | Company Description Genova Diagnostics performs diagnostics and molecular genetics testing under federally-designated clinical lab standards to support physicians in personalized chronic disease treatment and prevention. | Location Asheville | |
Company Inceptor Bio LLC | Activity: Research and Development | Company Description Inceptor Bio develops next-generation cell therapy platforms, across multiple cell types, to cure cancers. Its site includes a manufacturing facility for production of its therapies. | Location Raleigh | |
Company Inivata Inc. | Activity: Research and Development | Company Description Inivata develops a noninvasive liquid biopsy diagnostic using the precision of circulating tumor DNA (ctDNA) analysis for improving cancer detection and assessing individual response to treatment. | Location Research Triangle Park | |
Company Jaguar Gene Therapy LLC (Analytical Development) | Activity: Research and Development | Company Description Jaguar Gene Therapy develops gene therapies for patients suffering from severe genetic diseases. The company's analytical development lab is located in Durham. | Location Durham | |
Company Novartis Gene Therapies | Activity: Production and Manufacturing | Company Description Novartis Gene Therapies develops and commercializes gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The Durham site is Novartis Gene Therapies' manufacturing operations. | Location Durham | |
Company ProKidney (Winston-Salem) | Activity: Production and Manufacturing | Company Description ProKidney manufactures cell therapy products that use a patient's own cells to restore damaged kidney tissues by engrafting into, repairing or replacing damaged tissues or organs. | Location Winston-Salem | |
Company Q² Solutions | Activity: Contract Research and Testing | Company Description Q² Solutions provides global clinical trial laboratory services including comprehensive testing, project management, supply chain, biospecimen and consent management solutions. | Location Morrisville | |
Company Sanesco International Inc. | Activity: Research and Development | Company Description Sanesco develops clinical tools for healthcare providers, such as neuroendocrine analytical testing, nutritional support formulas and patient-centered clinical review. The NeuroLab division conducts research and development of in vitro diagnostic tools. | Location Arden | |
Company Sumitomo Pharma America Inc. (Cary) | Activity: Research and Development | Company Description Sumitomo Pharma America develops regenerative therapeutics for rare diseases such as congenital athymia. | Location Cary | |
Company Tune Therapeutics | Activity: Research and Development | Company Description Tune Therapeutics develops novel cell and gene therapy products with their epigenome editing and gene regulation platform, TEMPO. | Location Durham | |
Company Xilis Inc. | Activity: Research and Development | Company Description Xilis is developing microfluidic droplet-based patient-derived organoid (MDPDO) technology to guide precision therapy for cancer patients and accelerate drug discovery. | Location Durham |